These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34979748)

  • 21. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
    Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
    Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelioid dedifferentiated liposarcoma: A clinicopathological and molecular study of 6 cases.
    Tu Y; Zhu P; Lao IW; Yu L; Wang J
    Ann Diagn Pathol; 2023 Dec; 67():152203. PubMed ID: 37634346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
    Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
    Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
    Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
    Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
    Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
    J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superficial dedifferentiated liposarcoma: A clinicopathologic study.
    Bourgeau M; Gandhi JS; Deeb KK; Bahrami A
    Hum Pathol; 2024 Mar; 145():63-70. PubMed ID: 38423223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
    Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
    World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DDIT3-amplified or low-polysomic pleomorphic sarcomas without MDM2 amplification: Clinicopathological review and immunohistochemical profile of nine cases.
    Mori T; Iwasaki T; Sonoda H; Kawaguchi K; Tomonaga T; Furukawa H; Sato C; Shiraishi S; Taguchi K; Tamiya S; Yoneda R; Oshiro Y; Matsunobu T; Abe C; Kuboyama Y; Ueki N; Kohashi K; Yamamoto H; Nakashima Y; Oda Y
    Hum Pathol; 2024 Mar; 145():56-62. PubMed ID: 38401716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience.
    Cho J; Lee SE; Choi YL
    Korean J Pathol; 2012 Apr; 46(2):115-22. PubMed ID: 23109990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma.
    Yamashita K; Kohashi K; Yamada Y; Akatsuka S; Ikuta K; Nishida Y; Toyokuni S; Oda Y
    Genes Chromosomes Cancer; 2021 Jan; 60(1):26-37. PubMed ID: 33111425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dedifferentiated liposarcoma with heterologous spindle cell rhabdomyoblastic de-differentiation: An unusual pattern expanding the morphological spectrum.
    Rekhi B; Baheti AD; Patkar S
    Indian J Pathol Microbiol; 2020; 63(4):630-633. PubMed ID: 33154322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Accuracy of Immunohistochemical Expression of p16, MDM2, and CDK4 in Well-Differentiated and De-Differentiated Liposarcoma in MDM2 Fluorescent in situ Hybridisation Confirmed Cases.
    Aslam A; Din HU; Qadir A; Aslam U; Humayoun S; Ahmed W
    J Coll Physicians Surg Pak; 2024 Sep; 34(9):1051-1055. PubMed ID: 39262004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histological, immunohistochemical and molecular study of a paratesticular dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features].
    Machado I; Martí Ibor E; Berbegall AP; Alcácer Fernández-Coronado J; Claramunt R; Duarte Novo JE; Mosquera Reboredo J; Concha López Á; Alcácer García J
    Rev Esp Patol; 2022; 55(3):212-217. PubMed ID: 35779890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleomorphic liposarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic study of 32 additional cases.
    Wang L; Ren W; Zhou X; Sheng W; Wang J
    Pathol Int; 2013 Nov; 63(11):523-31. PubMed ID: 24274714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features.
    Makise N; Yoshida A; Komiyama M; Nakatani F; Yonemori K; Kawai A; Fukayama M; Hiraoka N
    Am J Surg Pathol; 2017 Nov; 41(11):1523-1531. PubMed ID: 28719466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.